Research and Markets

Target Product Profiles 2009: Physician Insights on Key Attributes: Prostate Cancer Metastatic Hormone-Refractory

Published in Health Business Week, April 2nd, 2010

Research and Marketshas announced the addition of Decision Resources, Inc.'s new report "Target Product Profiles 2009: Physician Insights on Key Attributes: Prostate Cancer (Metastatic Hormone-Refractory )" to their offering.

Prostate Cancer (Metastatic, Hormone Refractory): A therapy that has greater overall survival than docetaxel/prednisone

Using Target Product Profiles in Your Market Strategy

Keywords: Consumer, Health, Hormones, Men, Oncology, Prostate Cancer, Prostatic Neoplasms, Research and Markets.

This article was prepared by...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2010-04-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry